Abstract Details

Title Mediterranean Diet Score is Associated with Disability and Brain Atrophy in Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) S14 - MS Therapeutics (3:42 PM-3:54 PM)

Poster/Presentation
Number 002

Background

The MS community has a high interest in whether diet can act as a disease-modifier. Mediterranean diet score is associated with structural brain metrics and clinical outcomes in cognitive aging, suggesting potential neuroprotection. We have previously noted a relationship between a similar score (MIND, Mediterranean-DASH Intervention for Neurodegenerative Delay) and thalamic volume in early MS. Here we evaluated the relationship between Mediterranean diet score and MS-related disability in a representative clinical MS cohort.

Objective

To evaluate relationships between Mediterranean diet score and disability in multiple sclerosis (MS)

Design/Methods

Persons with MS (n=500; 70% women; aged 43.8±11.6 years) completed the Mediterranean Diet Adherence Screener (MEDAS) and the Multiple Sclerosis Functional Composite (MSFC) evaluation of cognition, upper extremity coordination, and gait speed. We measured third ventricle width (TVW) on axial T1 images from clinical MRIs as a validated estimate of cerebral atrophy. Multiple regressions investigated the independent contribution of MEDAS to MSFC and TVW controlling for age, sex, race, ethnicity, socioeconomic status, BMI, physical exercise, sleep disturbance, and a cardiovascular risk (CVR) index (hypertension, diabetes, hyperlipidemia, cardiac conditions, smoking).

Results Higher MEDAS independently predicted better MSFC (r_p=0.200, p<0.001) and lower TVW (less atrophy; r_p=-0.122, p=0.007). MEDAS was a much better predictor of both MSFC and TVW than were BMI, exercise, sleep disturbance, or CVR. The link between MEDAS and MSFC was strongest in progressive disease. The relationship between higher MEDAS and better MSFC was partially mediated through lower TVW (r_pΔ: 0.200 to 0.167, Ps<0.001), consistent with the notion that MEDAS preserves functional outcomes by supporting brain maintenance.

Conclusions

After controlling for important potential confounders, a significant association remains between Mediterranean diet score and MS-related disability. The strength of the relationship in progressive disease and partial mediation by third ventricle width suggests the possibility of a neuroprotective mechanism. Longitudinal studies and interventional clinical trials are needed.

Authors/Disclosures
Ilana B. Katz Sand, MD (Corinne Goldsmith Dickinson Center for MS) PRESENTER	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Kathryn Fitzgerald, PhD (Johns Hopkins University)	The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Tali R. Sorets	Tali R. Sorets has nothing to disclose.
	No disclosure on file
James F. Sumowski (Icahn School of Medicine At Mount Sinai)	Mr. Sumowski has nothing to disclose.